🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
25.90
-0.27 (-1.03%)
Nov 20, 2026, 12:24 PM EST - Market open

IDEAYA Biosciences Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, IDEAYA Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $50.15. The average 1-year stock price forecast is 93.63% higher than the current stock price, while the lowest is $30 (+15.83%) and the highest is $66 (+154.83%).

Price Target: $50.15 (+93.63%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$30$50.15$51$66
Change+15.83%+93.63%+96.91%+154.83%

Analyst Ratings

The average analyst rating for IDEAYA Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy111111101212
Buy333332
Hold211111
Sell000000
Strong Sell000000
Total161515141615

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$62 → $55
BuyReiterates$62 → $55+112.36%Nov 20, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$48
BuyMaintains$48+85.33%Nov 18, 2026
Wedbush
Wedbush
Buy
Maintains
$63
BuyMaintains$63+143.24%Nov 18, 2026
RBC Capital
RBC Capital
Buy
Maintains
$45
BuyMaintains$45+73.75%Nov 17, 2026
Citi
Citi
Buy
Reiterates
$66
BuyReiterates$66+154.83%Nov 17, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
41.04M
from 218.71M
Decreased by -81.24%
Revenue Next Year
117.38M
from 41.04M
Increased by 186.04%
EPS This Year
-4.76
from -1.28
EPS Next Year
-4.24
from -4.76
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
27.94M50.93M23.39M7.00M218.71M41.04M
Revenue Growth
43.01%82.28%-54.09%-70.07%3,024.43%-81.24%
Operating Income
-50.27M-62.50M-134.43M-326.98M-159.31M-496.16M
Net Income
-49.76M-58.66M-112.96M-274.48M-113.70M-458.57M
EPS
-----1.28-4.76
Free Cash Flow
-----73.47M-411.39M
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High75.7M
Avg41.0M
Low25.7M

Revenue Growth

Revenue Growth202620272028
High
-65.4%
Avg
-81.2%
Low
-88.3%

EPS Forecast

EPS202620272028
High-4.42
Avg-4.76
Low-5.07

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-